Structure

Physi-Chem Properties

Molecular Weight:  298.19
Volume:  333.205
LogP:  4.963
LogD:  4.328
LogS:  -5.413
# Rotatable Bonds:  1
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.782
Synthetic Accessibility Score:  3.473
Fsp3:  0.55
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.004
MDCK Permeability:  1.5221583453239873e-05
Pgp-inhibitor:  0.916
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.964
30% Bioavailability (F30%):  0.957

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.049
Plasma Protein Binding (PPB):  98.49134063720703%
Volume Distribution (VD):  1.197
Pgp-substrate:  3.1163954734802246%

ADMET: Metabolism

CYP1A2-inhibitor:  0.808
CYP1A2-substrate:  0.88
CYP2C19-inhibitor:  0.845
CYP2C19-substrate:  0.916
CYP2C9-inhibitor:  0.584
CYP2C9-substrate:  0.893
CYP2D6-inhibitor:  0.791
CYP2D6-substrate:  0.153
CYP3A4-inhibitor:  0.696
CYP3A4-substrate:  0.706

ADMET: Excretion

Clearance (CL):  3.833
Half-life (T1/2):  0.153

ADMET: Toxicity

hERG Blockers:  0.054
Human Hepatotoxicity (H-HT):  0.243
Drug-inuced Liver Injury (DILI):  0.284
AMES Toxicity:  0.202
Rat Oral Acute Toxicity:  0.38
Maximum Recommended Daily Dose:  0.881
Skin Sensitization:  0.247
Carcinogencity:  0.718
Eye Corrosion:  0.006
Eye Irritation:  0.868
Respiratory Toxicity:  0.913

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC72667

Natural Product ID:  NPC72667
Common Name*:   5,6-Dehydrosugiol
IUPAC Name:   (4aS)-6-hydroxy-1,1,4a-trimethyl-7-propan-2-yl-3,4-dihydro-2H-phenanthren-9-one
Synonyms:  
Standard InCHIKey:  HUMGJQLBBAYPNM-HXUWFJFHSA-N
Standard InCHI:  InChI=1S/C20H26O2/c1-12(2)13-9-14-15(10-16(13)21)20(5)8-6-7-19(3,4)18(20)11-17(14)22/h9-12,21H,6-8H2,1-5H3/t20-/m1/s1
SMILES:  O=C1C=C2C(C)(C)CCC[C@@]2(c2c1cc(C(C)C)c(c2)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3093123
PubChem CID:   14827280
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. root n.a. PMID[11374966]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[16038550]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[17583950]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[18855446]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[20455578]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[21775156]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[23286284]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[24108414]
NPO18892 Salvinia molesta Species Salviniaceae Eukaryota whole plants east Texas, USA 2009-2011 PMID[24210499]
NPO18892 Salvinia molesta Species Salviniaceae Eukaryota n.a. n.a. n.a. PMID[24210499]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[27569393]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[29185738]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[30351923]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. root n.a. PMID[3655791]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota roots n.a. n.a. PMID[9834151]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2267 Liatris tenuifolia Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO2267 Liatris tenuifolia Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO8215 Crepis zacintha Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2267 Liatris tenuifolia Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO18892 Salvinia molesta Species Salviniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7646 Edgeworthia chrysantha Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens GI50 = 92780.0 nM PMID[515510]
NPT306 Cell Line PC-3 Homo sapiens GI50 > 100000.0 nM PMID[515510]
NPT81 Cell Line A549 Homo sapiens GI50 = 84520.0 nM PMID[515510]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 > 100000.0 nM PMID[515510]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC72667 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9917 High Similarity NPC254492
0.9836 High Similarity NPC171460
0.9835 High Similarity NPC78364
0.9835 High Similarity NPC84672
0.9835 High Similarity NPC176130
0.9835 High Similarity NPC69424
0.975 High Similarity NPC199273
0.9597 High Similarity NPC108129
0.9593 High Similarity NPC96024
0.9583 High Similarity NPC282577
0.952 High Similarity NPC471851
0.9516 High Similarity NPC276238
0.9516 High Similarity NPC303910
0.95 High Similarity NPC154696
0.9435 High Similarity NPC3009
0.937 High Similarity NPC78307
0.937 High Similarity NPC477139
0.937 High Similarity NPC138472
0.935 High Similarity NPC123506
0.9297 High Similarity NPC202225
0.9256 High Similarity NPC259703
0.9256 High Similarity NPC32322
0.9219 High Similarity NPC111845
0.9084 High Similarity NPC36868
0.9084 High Similarity NPC475957
0.9055 High Similarity NPC117899
0.904 High Similarity NPC137750
0.9032 High Similarity NPC273683
0.9015 High Similarity NPC230811
0.9008 High Similarity NPC471670
0.8976 High Similarity NPC193203
0.8968 High Similarity NPC71610
0.8952 High Similarity NPC176208
0.8939 High Similarity NPC53001
0.8931 High Similarity NPC153088
0.8915 High Similarity NPC239134
0.8915 High Similarity NPC18798
0.888 High Similarity NPC471187
0.888 High Similarity NPC275145
0.8872 High Similarity NPC87723
0.8871 High Similarity NPC162935
0.8871 High Similarity NPC249340
0.8855 High Similarity NPC12070
0.8855 High Similarity NPC50924
0.8828 High Similarity NPC229894
0.8819 High Similarity NPC15837
0.881 High Similarity NPC181334
0.88 High Similarity NPC11250
0.8797 High Similarity NPC277559
0.879 High Similarity NPC241001
0.8788 High Similarity NPC249272
0.8779 High Similarity NPC114183
0.8769 High Similarity NPC164295
0.8741 High Similarity NPC471853
0.8722 High Similarity NPC474311
0.872 High Similarity NPC120545
0.8712 High Similarity NPC270899
0.8702 High Similarity NPC165612
0.8692 High Similarity NPC253488
0.8686 High Similarity NPC100242
0.8682 High Similarity NPC48248
0.8657 High Similarity NPC49911
0.8651 High Similarity NPC91478
0.8651 High Similarity NPC307174
0.8651 High Similarity NPC121168
0.8647 High Similarity NPC477596
0.8647 High Similarity NPC283088
0.864 High Similarity NPC190971
0.8636 High Similarity NPC53896
0.8636 High Similarity NPC4170
0.8636 High Similarity NPC59459
0.8626 High Similarity NPC17083
0.8626 High Similarity NPC476847
0.8626 High Similarity NPC244699
0.8626 High Similarity NPC41847
0.8626 High Similarity NPC93015
0.8615 High Similarity NPC34414
0.8615 High Similarity NPC146647
0.8615 High Similarity NPC25736
0.8613 High Similarity NPC308572
0.8613 High Similarity NPC248068
0.8613 High Similarity NPC477209
0.8607 High Similarity NPC322197
0.8605 High Similarity NPC471530
0.8605 High Similarity NPC19432
0.8603 High Similarity NPC169452
0.8603 High Similarity NPC181560
0.8595 High Similarity NPC242136
0.8583 High Similarity NPC198014
0.8583 High Similarity NPC174991
0.8582 High Similarity NPC7464
0.8582 High Similarity NPC472308
0.8582 High Similarity NPC191976
0.8571 High Similarity NPC477594
0.8571 High Similarity NPC253627
0.8561 High Similarity NPC478160
0.8561 High Similarity NPC183103
0.8561 High Similarity NPC58685
0.856 High Similarity NPC190501
0.856 High Similarity NPC318552
0.856 High Similarity NPC478121
0.855 High Similarity NPC27659
0.8529 High Similarity NPC138099
0.8529 High Similarity NPC242994
0.8527 High Similarity NPC474737
0.8527 High Similarity NPC3224
0.8527 High Similarity NPC160499
0.8519 High Similarity NPC471905
0.8516 High Similarity NPC173978
0.8516 High Similarity NPC142956
0.8516 High Similarity NPC164014
0.8512 High Similarity NPC231717
0.8512 High Similarity NPC250323
0.8507 High Similarity NPC80035
0.8507 High Similarity NPC22644
0.8507 High Similarity NPC290803
0.8496 Intermediate Similarity NPC49742
0.8496 Intermediate Similarity NPC267205
0.8496 Intermediate Similarity NPC115458
0.8496 Intermediate Similarity NPC225051
0.8496 Intermediate Similarity NPC52407
0.8492 Intermediate Similarity NPC472981
0.8489 Intermediate Similarity NPC309169
0.8489 Intermediate Similarity NPC196941
0.8485 Intermediate Similarity NPC72669
0.8485 Intermediate Similarity NPC291001
0.8485 Intermediate Similarity NPC474517
0.848 Intermediate Similarity NPC42657
0.8478 Intermediate Similarity NPC193555
0.8478 Intermediate Similarity NPC184935
0.8478 Intermediate Similarity NPC201297
0.8473 Intermediate Similarity NPC99731
0.8468 Intermediate Similarity NPC174087
0.8467 Intermediate Similarity NPC476534
0.8456 Intermediate Similarity NPC51531
0.8456 Intermediate Similarity NPC46242
0.8456 Intermediate Similarity NPC157284
0.8456 Intermediate Similarity NPC23667
0.8456 Intermediate Similarity NPC13715
0.8456 Intermediate Similarity NPC4214
0.8456 Intermediate Similarity NPC473479
0.8456 Intermediate Similarity NPC473779
0.8456 Intermediate Similarity NPC165191
0.8456 Intermediate Similarity NPC114333
0.8456 Intermediate Similarity NPC289358
0.8456 Intermediate Similarity NPC469857
0.8456 Intermediate Similarity NPC42384
0.8456 Intermediate Similarity NPC5014
0.8456 Intermediate Similarity NPC297797
0.8456 Intermediate Similarity NPC50615
0.8456 Intermediate Similarity NPC28592
0.8456 Intermediate Similarity NPC149773
0.8456 Intermediate Similarity NPC477849
0.8456 Intermediate Similarity NPC245760
0.8456 Intermediate Similarity NPC91887
0.845 Intermediate Similarity NPC87985
0.8444 Intermediate Similarity NPC254847
0.844 Intermediate Similarity NPC5568
0.8433 Intermediate Similarity NPC282780
0.8433 Intermediate Similarity NPC166480
0.843 Intermediate Similarity NPC260323
0.843 Intermediate Similarity NPC176279
0.8421 Intermediate Similarity NPC312560
0.8421 Intermediate Similarity NPC175738
0.8417 Intermediate Similarity NPC478164
0.8413 Intermediate Similarity NPC285829
0.8413 Intermediate Similarity NPC206778
0.8409 Intermediate Similarity NPC55949
0.8397 Intermediate Similarity NPC282923
0.8394 Intermediate Similarity NPC294330
0.8387 Intermediate Similarity NPC471668
0.8387 Intermediate Similarity NPC477453
0.8385 Intermediate Similarity NPC306765
0.8382 Intermediate Similarity NPC53206
0.8382 Intermediate Similarity NPC477592
0.8382 Intermediate Similarity NPC53414
0.8382 Intermediate Similarity NPC119542
0.8372 Intermediate Similarity NPC68756
0.8372 Intermediate Similarity NPC152525
0.837 Intermediate Similarity NPC258502
0.8369 Intermediate Similarity NPC143685
0.8359 Intermediate Similarity NPC300274
0.8358 Intermediate Similarity NPC263817
0.8347 Intermediate Similarity NPC13482
0.8346 Intermediate Similarity NPC216216
0.8346 Intermediate Similarity NPC85342
0.8345 Intermediate Similarity NPC135524
0.8345 Intermediate Similarity NPC19631
0.8345 Intermediate Similarity NPC239136
0.8333 Intermediate Similarity NPC131684
0.8333 Intermediate Similarity NPC79933
0.8333 Intermediate Similarity NPC31296
0.8333 Intermediate Similarity NPC258366
0.8333 Intermediate Similarity NPC473527
0.8333 Intermediate Similarity NPC92624
0.8333 Intermediate Similarity NPC473767
0.8333 Intermediate Similarity NPC473974
0.8321 Intermediate Similarity NPC471974
0.8321 Intermediate Similarity NPC469680
0.8321 Intermediate Similarity NPC61398

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC72667 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.871 High Similarity NPD2932 Approved
0.8629 High Similarity NPD4196 Clinical (unspecified phase)
0.856 High Similarity NPD3019 Approved
0.8444 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8281 Intermediate Similarity NPD1201 Approved
0.8168 Intermediate Similarity NPD1470 Approved
0.8099 Intermediate Similarity NPD7390 Discontinued
0.8095 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD7003 Approved
0.7986 Intermediate Similarity NPD5404 Approved
0.7986 Intermediate Similarity NPD5405 Approved
0.7986 Intermediate Similarity NPD5406 Approved
0.7986 Intermediate Similarity NPD5408 Approved
0.7937 Intermediate Similarity NPD5951 Approved
0.7923 Intermediate Similarity NPD3026 Approved
0.7923 Intermediate Similarity NPD3023 Approved
0.7907 Intermediate Similarity NPD3025 Approved
0.7907 Intermediate Similarity NPD3024 Approved
0.7803 Intermediate Similarity NPD3972 Approved
0.771 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD7458 Discontinued
0.7681 Intermediate Similarity NPD6663 Approved
0.7671 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7655 Intermediate Similarity NPD3300 Phase 2
0.7647 Intermediate Similarity NPD5736 Approved
0.7639 Intermediate Similarity NPD8166 Discontinued
0.7638 Intermediate Similarity NPD7635 Approved
0.763 Intermediate Similarity NPD1164 Approved
0.7606 Intermediate Similarity NPD6099 Approved
0.7606 Intermediate Similarity NPD6100 Approved
0.7576 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD3091 Approved
0.7556 Intermediate Similarity NPD1283 Approved
0.7552 Intermediate Similarity NPD2346 Discontinued
0.752 Intermediate Similarity NPD2342 Discontinued
0.75 Intermediate Similarity NPD943 Approved
0.75 Intermediate Similarity NPD1651 Approved
0.7483 Intermediate Similarity NPD2935 Discontinued
0.746 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7445 Intermediate Similarity NPD2798 Approved
0.7444 Intermediate Similarity NPD4626 Approved
0.7444 Intermediate Similarity NPD4059 Approved
0.7417 Intermediate Similarity NPD1809 Phase 2
0.7413 Intermediate Similarity NPD2799 Discontinued
0.7402 Intermediate Similarity NPD4750 Phase 3
0.7397 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1607 Approved
0.7383 Intermediate Similarity NPD6273 Approved
0.7381 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD3020 Approved
0.7357 Intermediate Similarity NPD3764 Approved
0.7355 Intermediate Similarity NPD3495 Discontinued
0.7355 Intermediate Similarity NPD288 Approved
0.7353 Intermediate Similarity NPD1755 Approved
0.7351 Intermediate Similarity NPD3226 Approved
0.7333 Intermediate Similarity NPD1281 Approved
0.7333 Intermediate Similarity NPD3092 Approved
0.7329 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD2344 Approved
0.7299 Intermediate Similarity NPD1876 Approved
0.7292 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD4628 Phase 3
0.7279 Intermediate Similarity NPD3750 Approved
0.7279 Intermediate Similarity NPD4878 Approved
0.7273 Intermediate Similarity NPD7819 Suspended
0.7273 Intermediate Similarity NPD844 Approved
0.726 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD1240 Approved
0.725 Intermediate Similarity NPD7473 Discontinued
0.7237 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7218 Intermediate Similarity NPD7610 Discontinued
0.7215 Intermediate Similarity NPD6959 Discontinued
0.7209 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD2532 Approved
0.72 Intermediate Similarity NPD2534 Approved
0.72 Intermediate Similarity NPD1929 Approved
0.72 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD1930 Approved
0.72 Intermediate Similarity NPD2533 Approved
0.72 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD3095 Discontinued
0.7183 Intermediate Similarity NPD8032 Phase 2
0.7177 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD1510 Phase 2
0.717 Intermediate Similarity NPD6232 Discontinued
0.7164 Intermediate Similarity NPD9545 Approved
0.7163 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD7008 Discontinued
0.7154 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD6651 Approved
0.7132 Intermediate Similarity NPD3021 Approved
0.7132 Intermediate Similarity NPD3022 Approved
0.7131 Intermediate Similarity NPD2859 Approved
0.7131 Intermediate Similarity NPD2860 Approved
0.7122 Intermediate Similarity NPD3094 Phase 2
0.7114 Intermediate Similarity NPD2309 Approved
0.7114 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD5691 Approved
0.7107 Intermediate Similarity NPD845 Approved
0.7101 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD2066 Phase 3
0.7095 Intermediate Similarity NPD2800 Approved
0.7086 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1751 Approved
0.7059 Intermediate Similarity NPD2286 Discontinued
0.7054 Intermediate Similarity NPD74 Approved
0.7054 Intermediate Similarity NPD9266 Approved
0.7051 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD2933 Approved
0.7049 Intermediate Similarity NPD2934 Approved
0.7037 Intermediate Similarity NPD7009 Phase 2
0.7034 Intermediate Similarity NPD4097 Suspended
0.7021 Intermediate Similarity NPD4208 Discontinued
0.7015 Intermediate Similarity NPD9493 Approved
0.7014 Intermediate Similarity NPD2979 Phase 3
0.7006 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2797 Approved
0.6993 Remote Similarity NPD2313 Discontinued
0.6993 Remote Similarity NPD3268 Approved
0.6985 Remote Similarity NPD4093 Discontinued
0.6977 Remote Similarity NPD9263 Approved
0.6977 Remote Similarity NPD9267 Approved
0.6977 Remote Similarity NPD9264 Approved
0.6968 Remote Similarity NPD4380 Phase 2
0.6954 Remote Similarity NPD7236 Approved
0.6951 Remote Similarity NPD6020 Phase 2
0.6951 Remote Similarity NPD5844 Phase 1
0.6939 Remote Similarity NPD3748 Approved
0.6939 Remote Similarity NPD4308 Phase 3
0.6913 Remote Similarity NPD1549 Phase 2
0.6906 Remote Similarity NPD9269 Phase 2
0.6906 Remote Similarity NPD1608 Approved
0.6901 Remote Similarity NPD3635 Approved
0.6901 Remote Similarity NPD9494 Approved
0.6901 Remote Similarity NPD3636 Approved
0.6901 Remote Similarity NPD3637 Approved
0.6897 Remote Similarity NPD4060 Phase 1
0.6894 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6892 Remote Similarity NPD2796 Approved
0.6889 Remote Similarity NPD7325 Clinical (unspecified phase)
0.6884 Remote Similarity NPD4879 Approved
0.6875 Remote Similarity NPD1237 Approved
0.6863 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6861 Remote Similarity NPD9268 Approved
0.6859 Remote Similarity NPD6599 Discontinued
0.6859 Remote Similarity NPD7028 Phase 2
0.6853 Remote Similarity NPD2605 Approved
0.6853 Remote Similarity NPD2606 Approved
0.6853 Remote Similarity NPD4207 Discontinued
0.6846 Remote Similarity NPD1471 Phase 3
0.6846 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6846 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6846 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6845 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6842 Remote Similarity NPD6884 Clinical (unspecified phase)
0.6839 Remote Similarity NPD7239 Suspended
0.6831 Remote Similarity NPD2194 Approved
0.6831 Remote Similarity NPD2195 Approved
0.6831 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6831 Remote Similarity NPD4624 Approved
0.6824 Remote Similarity NPD8150 Discontinued
0.6815 Remote Similarity NPD7411 Suspended
0.6813 Remote Similarity NPD7075 Discontinued
0.6812 Remote Similarity NPD4589 Approved
0.6809 Remote Similarity NPD6696 Suspended
0.6806 Remote Similarity NPD5155 Approved
0.6806 Remote Similarity NPD4625 Phase 3
0.6806 Remote Similarity NPD5156 Approved
0.6797 Remote Similarity NPD1511 Approved
0.6791 Remote Similarity NPD1241 Discontinued
0.6791 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6788 Remote Similarity NPD7177 Discontinued
0.6781 Remote Similarity NPD4140 Approved
0.6781 Remote Similarity NPD3620 Phase 2
0.6781 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6779 Remote Similarity NPD2531 Phase 2
0.6779 Remote Similarity NPD4477 Approved
0.6779 Remote Similarity NPD4476 Approved
0.6779 Remote Similarity NPD2438 Suspended
0.6772 Remote Similarity NPD1934 Approved
0.6763 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6759 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7631 Approved
0.6744 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6742 Remote Similarity NPD1792 Phase 2
0.6741 Remote Similarity NPD2629 Approved
0.6741 Remote Similarity NPD497 Approved
0.6738 Remote Similarity NPD4749 Approved
0.6738 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6736 Remote Similarity NPD3595 Approved
0.6736 Remote Similarity NPD3594 Approved
0.6735 Remote Similarity NPD230 Phase 1
0.673 Remote Similarity NPD7096 Clinical (unspecified phase)
0.673 Remote Similarity NPD2801 Approved
0.6719 Remote Similarity NPD940 Approved
0.6719 Remote Similarity NPD1932 Approved
0.6719 Remote Similarity NPD846 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data